DK2956150T3 - Serumfraktion af trombocyt-rig fibrin - Google Patents
Serumfraktion af trombocyt-rig fibrin Download PDFInfo
- Publication number
- DK2956150T3 DK2956150T3 DK14707886.9T DK14707886T DK2956150T3 DK 2956150 T3 DK2956150 T3 DK 2956150T3 DK 14707886 T DK14707886 T DK 14707886T DK 2956150 T3 DK2956150 T3 DK 2956150T3
- Authority
- DK
- Denmark
- Prior art keywords
- thrombocyt
- fibrine
- rig
- serum fraction
- serum
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/19—Platelets; Megacaryocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/3616—Blood, e.g. platelet-rich plasma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
- A61K35/10—Peat; Amber; Turf; Humus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/06—Flowable or injectable implant compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Pharmacology & Pharmacy (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Botany (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Dispersion Chemistry (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361763504P | 2013-02-12 | 2013-02-12 | |
| PCT/US2014/015962 WO2014126970A1 (en) | 2013-02-12 | 2014-02-12 | Serum fraction of platelet-rich fibrin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2956150T3 true DK2956150T3 (da) | 2021-11-01 |
Family
ID=50193598
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK14707886.9T DK2956150T3 (da) | 2013-02-12 | 2014-02-12 | Serumfraktion af trombocyt-rig fibrin |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US9480716B2 (da) |
| EP (1) | EP2956150B1 (da) |
| AU (1) | AU2014216415B2 (da) |
| CA (1) | CA2900971C (da) |
| DK (1) | DK2956150T3 (da) |
| ES (1) | ES2896338T3 (da) |
| HU (1) | HUE056391T2 (da) |
| IL (1) | IL240437B (da) |
| PL (1) | PL2956150T3 (da) |
| RU (1) | RU2711330C2 (da) |
| SG (1) | SG11201506259WA (da) |
| SI (1) | SI2956150T1 (da) |
| WO (1) | WO2014126970A1 (da) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017193134A1 (en) * | 2016-05-06 | 2017-11-09 | Lacerta Technologies Inc. | Mesenchymal stem cell proliferation |
| WO2017152172A1 (en) * | 2016-03-04 | 2017-09-08 | Lacerta Technologies Inc. | Chondrocyte proliferation |
| CN105636599A (zh) | 2013-08-27 | 2016-06-01 | 库克通用生物技术有限责任公司 | 可来源于血小板浓缩液的生物活性组合物及其制备和使用方法 |
| ES2564580B1 (es) * | 2014-09-22 | 2016-12-28 | Biotechnology Institute, I Mas D, S.L. | Método de preparación de una composición rica en plaquetas y/o factores de crecimiento |
| CN104337835B (zh) * | 2014-11-13 | 2018-11-20 | 河南金泰生物技术股份有限公司 | 一种富血小板血浆的制备方法 |
| EP3092987A1 (de) * | 2015-05-11 | 2016-11-16 | 3M Innovative Properties Company | System zur wundbehandlung mit serum |
| EP3383269B1 (en) | 2015-12-03 | 2020-02-19 | Lacerta Technologies Inc. | Apparatus for preparing blood fraction concentrate |
| WO2018212758A1 (en) * | 2017-05-15 | 2018-11-22 | Miron Richard J | Liquid platelet-rich fibrin as a carrier system for biomaterials and biomolecules |
| TW201936627A (zh) * | 2018-02-26 | 2019-09-16 | 鄭本岡 | 具有高活化細胞因子的血清之備製方法 |
| WO2020163787A1 (en) * | 2019-02-07 | 2020-08-13 | Biobridge Global | Methods and compositions related to platelet releasate and platelet-rich fibrin |
| TR201908181A2 (tr) * | 2019-05-29 | 2020-12-21 | Univ Istanbul Rektoerluegue | Trombosi̇t konsantresi̇ i̇le vi̇tami̇n/mi̇neral i̇laç/hormon/enzi̇m/bi̇yomateryal bi̇leşi̇mi̇ni̇n eldesi̇ |
| WO2021206669A1 (en) * | 2020-04-06 | 2021-10-14 | Reosteon, Llc | Method and apparatus for ensuring maintenance and integrity of surgical implant survival in human and veterinary patients |
| RU2761726C1 (ru) * | 2021-06-01 | 2021-12-13 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Воронежский государственный медицинский университет им. Н.Н. Бурденко" Министерства здравоохранения Российской Федерации | Способ лечения пациентов с одонтогенным остеомиелитом |
| CN115463249A (zh) * | 2022-08-11 | 2022-12-13 | 中南大学湘雅医院 | 一种负载富血小板血浆水凝胶及其制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000062828A1 (en) | 1996-04-30 | 2000-10-26 | Medtronic, Inc. | Autologous fibrin sealant and method for making the same |
| DE102006005016A1 (de) | 2006-02-03 | 2007-08-16 | Orthogen Ag | Konditionierte Blutzusammensetzung und Verfahren zu deren Herstellung |
| WO2007127834A2 (en) | 2006-04-26 | 2007-11-08 | Medtronic, Inc. | Compositions and methods of preparation thereof |
| WO2010020247A1 (en) | 2008-08-22 | 2010-02-25 | Reapplix Aps | Multilayered blood product |
| BRPI1005434A2 (pt) | 2009-02-05 | 2019-09-24 | Philippart Pierre | uso de plasma rico em plaquetas e um fator de coagulação, uso do medicamento, kit de componentes, amostra de medula óssea, fator de coagulação, método para cultura in vitro de células estaminais embriônicas humanas, método para obter uma popolação celular enriquecida em celulas estaminais mesenquinais ativadas, método para obter células estsminais humanas embriônicas, composição em gel e método para aumentar uma concentração sanguínea de citoquinas de um indivíduo mamífero |
| WO2013116791A1 (en) * | 2012-02-02 | 2013-08-08 | Mosaic Biosciences, Inc. | Biomaterials for delivery of blood extracts and methods of using same |
-
2014
- 2014-02-12 CA CA2900971A patent/CA2900971C/en active Active
- 2014-02-12 ES ES14707886T patent/ES2896338T3/es active Active
- 2014-02-12 RU RU2015137965A patent/RU2711330C2/ru active
- 2014-02-12 EP EP14707886.9A patent/EP2956150B1/en active Active
- 2014-02-12 AU AU2014216415A patent/AU2014216415B2/en active Active
- 2014-02-12 US US14/178,573 patent/US9480716B2/en active Active
- 2014-02-12 HU HUE14707886A patent/HUE056391T2/hu unknown
- 2014-02-12 WO PCT/US2014/015962 patent/WO2014126970A1/en active Application Filing
- 2014-02-12 DK DK14707886.9T patent/DK2956150T3/da active
- 2014-02-12 SG SG11201506259WA patent/SG11201506259WA/en unknown
- 2014-02-12 SI SI201431897T patent/SI2956150T1/sl unknown
- 2014-02-12 PL PL14707886T patent/PL2956150T3/pl unknown
-
2015
- 2015-08-09 IL IL240437A patent/IL240437B/en active IP Right Grant
-
2016
- 2016-10-03 US US15/283,576 patent/US10111906B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| SI2956150T1 (sl) | 2022-02-28 |
| AU2014216415B2 (en) | 2016-12-15 |
| IL240437B (en) | 2019-06-30 |
| RU2015137965A (ru) | 2017-03-20 |
| SG11201506259WA (en) | 2015-09-29 |
| CA2900971C (en) | 2023-08-08 |
| HUE056391T2 (hu) | 2022-02-28 |
| EP2956150A1 (en) | 2015-12-23 |
| RU2711330C2 (ru) | 2020-01-16 |
| WO2014126970A1 (en) | 2014-08-21 |
| IL240437A0 (en) | 2015-09-24 |
| RU2015137965A3 (da) | 2018-02-28 |
| US10111906B2 (en) | 2018-10-30 |
| ES2896338T3 (es) | 2022-02-24 |
| CA2900971A1 (en) | 2014-08-21 |
| US20170035809A1 (en) | 2017-02-09 |
| AU2014216415A1 (en) | 2015-09-24 |
| US9480716B2 (en) | 2016-11-01 |
| EP2956150B1 (en) | 2021-08-11 |
| PL2956150T3 (pl) | 2022-01-03 |
| US20140227241A1 (en) | 2014-08-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2956150T3 (da) | Serumfraktion af trombocyt-rig fibrin | |
| DK3418929T3 (da) | Automatiseret screening af enzymvarianter | |
| DK2951203T3 (da) | Heterodimere proteiner | |
| DK3087183T3 (da) | Modulation af angiopoietin-3-lignende ekspression | |
| DK2970954T3 (da) | Modifikation af polypeptider | |
| DK3080100T3 (da) | Hæmmere af lysinspecifik demethylase-1 | |
| DK2961388T3 (da) | Kombinationer af lægemidler | |
| DK2970464T3 (da) | Anti-lag-3-bindende proteiner | |
| DK3336106T3 (da) | Anti-fcrh5-antistoffer | |
| DK3620534T3 (da) | Crispr-cas sammensætninger af nucleinsyre-targeting nucleinsyrer | |
| DK3027618T3 (da) | Polymorf af syk-hæmmere | |
| DK2845905T3 (da) | Fremstilling af oligosaccharider | |
| DK3586644T3 (da) | Fremstilling af bælgfrugtproteinprodukter med reduceret astringens | |
| DK3708583T3 (da) | Ikke-fucosylerede anti-fgfr2iiib-antistoffer | |
| DK3461895T3 (da) | Modulation af ube3a-ats-ekspression | |
| DK3041857T3 (da) | Protein a-kromatografi | |
| DK3010895T3 (da) | Fremgangsmåde til fremstilling af 4-propargyleret aminobenzoxazinoner | |
| DK3348556T3 (da) | Heteroarylamider som hæmmere af proteinaggregering | |
| DK3014279T3 (da) | Fremgangsmåde til bestemmelse af proteinaggregater under anvendelse af overflade-fida | |
| DK3680000T3 (da) | Fremgangsmåder til oprensning af antistoffer | |
| DK2943561T3 (da) | Fotobioreaktor | |
| DK3068800T3 (da) | FcRn-specifikke antistoffer | |
| DK2931313T3 (da) | Opløsningsformuleringer af manipulerede anti-il-23p19-antistoffer | |
| DK3065774T3 (da) | Anti-CCL17-antistoffer | |
| DK2822301T3 (da) | Bestemmelse af individuelle HRTF |